Latest Insider Transactions at Repare Therapeutics Inc. (RPTX)
This section provides a real-time view of insider transactions for Repare Therapeutics Inc. (RPTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Repare Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Repare Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
12,672
+50.0%
|
-
|
|
Feb 16
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
830
+4.27%
|
-
|
|
Feb 16
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
312,672
-82.07%
|
-
|
|
Feb 16
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
12,672
+50.0%
|
-
|
|
Feb 16
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
50,000
-9.84%
|
-
|
|
Jan 29
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
625,609
-59.29%
|
-
|
|
Jan 29
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
75,609
+38.23%
|
-
|
|
Jan 29
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
50,000
-8.96%
|
-
|
|
Jan 29
2021
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
675,609
-55.1%
|
-
|
|
Jan 29
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
75,609
+38.23%
|
-
|
|
Jan 29
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
5,277
+15.86%
|
-
|
|
Jan 29
2021
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
615,137
-51.02%
|
-
|
|
Jan 29
2021
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
15,137
+50.0%
|
-
|
|
Jan 29
2021
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
60,472
-100.0%
|
-
|
|
Jan 29
2021
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
60,472
+18.62%
|
-
|
|
Jan 14
2021
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
548,404
-53.38%
|
-
|
|
Jan 14
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
48,404
+38.23%
|
-
|
|
Jan 14
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
2,799
+25.97%
|
-
|
|
Jan 14
2021
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
513,128
-49.14%
|
-
|
|
Jan 14
2021
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
13,128
+50.0%
|
-
|
|
Jan 14
2021
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
35,276
-100.0%
|
-
|
|
Jan 14
2021
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
35,276
+18.63%
|
-
|
|
Jan 14
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
498,404
-57.48%
|
-
|
|
Jan 14
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
48,404
+38.23%
|
-
|
|
Jan 14
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
50,000
-8.22%
|
-
|
|
Dec 29
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
19,696
-10.03%
|
$669,664
$34.31 P/Share
|
|
Dec 28
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
15,048
-8.86%
|
$511,632
$34.42 P/Share
|
|
Dec 28
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
48
+0.06%
|
$96
$2.06 P/Share
|
|
Dec 24
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
432
-0.5%
|
$14,256
$33.14 P/Share
|
|
Dec 24
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
432
+0.5%
|
$864
$2.06 P/Share
|
|
Dec 23
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
16,235
-8.26%
|
$535,755
$33.87 P/Share
|
|
Dec 23
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,235
+5.23%
|
$32,470
$2.04 P/Share
|
|
Dec 22
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
41,312
-16.53%
|
$1,363,296
$33.68 P/Share
|
|
Dec 22
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
41,312
+15.15%
|
$41,312
$1.85 P/Share
|
|
Dec 21
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
40,000
-31.94%
|
$1,320,000
$33.08 P/Share
|
|
Dec 21
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+24.21%
|
$80,000
$2.42 P/Share
|
|
Dec 18
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
8,321
-4.46%
|
$282,914
$34.84 P/Share
|
|
Dec 18
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,321
+8.17%
|
$16,642
$2.06 P/Share
|
|
Dec 16
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
8,956
-4.8%
|
$313,460
$35.59 P/Share
|
|
Dec 16
2020
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,956
+4.55%
|
$8,956
$1.64 P/Share
|
|
Dec 15
2020
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
325,000
-10.12%
|
-
|
|
Dec 15
2020
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
325,000
-10.12%
|
-
|
|
Dec 15
2020
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
325,000
-10.12%
|
-
|
|
Jun 23
2020
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
774,200
+33.54%
|
$15,484,000
$20.0 P/Share
|
|
Jun 23
2020
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,601,325
+50.0%
|
-
|
|
Jun 23
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,586,174
+50.0%
|
-
|